NeuroMetrix Inc. announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement. Mr. McGillin brings to the company over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 USD | +0.81% |
|
+1.92% | +3.33% |
May. 15 | NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
+3.33% | 7.42M | |
-6.61% | 179B | |
-6.15% | 98.84B | |
-6.21% | 65.34B | |
+15.46% | 45.41B | |
-7.26% | 44.94B | |
+9.65% | 43.76B | |
+13.32% | 29.01B | |
+19.39% | 25.65B | |
-6.86% | 23.32B |
- Stock Market
- Equities
- NURO Stock
- News NeuroMetrix, Inc.
- NeuroMetrix Appoints Frank McGillin as Senior Vice President and General Manager, Consumer